Effects of chronic phenylpropanolamine infusion and termination on body weight, food consumption and water consumption in rats
- PMID: 7855211
- DOI: 10.1007/BF02249344
Effects of chronic phenylpropanolamine infusion and termination on body weight, food consumption and water consumption in rats
Abstract
The present study determined the effect of chronic PPA infusion and withdrawal on weight regulation. Male Sprague-Dawley rats received PPA (0, 90 or 180 mg/kg) via miniosmotic pumps for 2 weeks. Body weight and food and water consumption were measured daily before, during, and for 2 weeks after PPA infusion. Additionally, body weight was measured once 6 weeks after the last day of drug administration. PPA infusion produced dose-dependent reductions in body weight and food consumption throughout drug administration. During the first week of PPA termination, food consumption returned to control levels; however, body weights of drug-treated animals remained below those of controls throughout the 6-week post-drug period. PPA depressed water intake during the first week of drug administration, but tolerance to this effect developed by the second week of administration. These results suggest chronic PPA infusion produces persistent appetite suppression and weight loss and that discontinuation of PPA does not result in hyperphagia or rapid weight gain. These findings may have clinical significance for the many individuals who wish to lose weight but have difficulty reducing intake without pharmacologic assistance.
Similar articles
-
Effects of phenylpropanolamine infusion and withdrawal on body weight and dietary composition in male and female rats.Physiol Behav. 1993 Sep;54(3):523-30. doi: 10.1016/0031-9384(93)90246-c. Physiol Behav. 1993. PMID: 8415947
-
Use of phenylpropanolamine to reduce nicotine cessation induced weight gain in rats.Psychopharmacology (Berl). 1992;108(4):501-6. doi: 10.1007/BF02247428. Psychopharmacology (Berl). 1992. PMID: 1410166
-
Weight loss induced by chronic phenylpropanolamine: anorexia and brown adipose tissue thermogenesis.Pharmacol Biochem Behav. 1986 Mar;24(3):605-11. doi: 10.1016/0091-3057(86)90565-4. Pharmacol Biochem Behav. 1986. PMID: 3703896
-
The pharmacology of the anorexic effect of phenylpropanolamine.Drugs Exp Clin Res. 1990;16(9):487-95. Drugs Exp Clin Res. 1990. PMID: 2100250 Review.
-
A review of the physiological bases of the anorexic action of phenylpropanolamine (d,1-norephedrine).Neurosci Biobehav Rev. 1990 Fall;14(3):339-55. doi: 10.1016/s0149-7634(05)80043-0. Neurosci Biobehav Rev. 1990. PMID: 2234611 Review.
Cited by
-
The identification of neuropeptide Y receptor subtype involved in phenylpropanolamine-induced increase in oxidative stress and appetite suppression.Neuromolecular Med. 2013 Mar;15(1):159-68. doi: 10.1007/s12017-012-8206-x. Epub 2012 Nov 20. Neuromolecular Med. 2013. PMID: 23179670
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical